Loading insider details...
Beta
Latest Form 4 (May 14, 2026): Grant/Award of 22,700 TNXP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 14, 2026 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 22,700 | n/a |
| May 15, 2025 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 10,000 | n/a |
| Feb 28, 2025 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Other (see footnotes) | 1 | $0.15 |
| May 24, 2024 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 104,621 | n/a |
| May 10, 2023 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 60,000 | n/a |
| May 11, 2022 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 2,131,500 | n/a |
| May 12, 2021 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 270,882 | n/a |
| Aug 24, 2020 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Purchase | 5,391 | $5.0K |
| May 6, 2020 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Grant/Award | 75,000 | n/a |